What is PHAR's gross margin?

Pharming (PHAR) has a gross margin of 84% and a net margin of 2%.

What is PHAR's P/E ratio?

PHAR's P/E ratio is 66.6 with ROE of 4%.

Where can I see PHAR's full financials?

See Pharming (PHAR) income statement, cash flow, and balance sheet — quarterly and annual — alongside insider trading activity.

Pharming (PHAR) Financials — Revenue, Earnings, Cash Flow

Also trades as: PHARM.AS (AMS) · $vol 9M · PHGUF (OTC) · $vol 0M

$9.75

-0.20 (-2.01%)

Weekly Expected Move ±6.1%

$9 $9 $10 $10 $11

NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 34 · $690.1M mcap · 73M float · 0.026% daily turnover · Short 40% of daily vol

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions ETF Exposure Dark Pool Short Interest

📊 Key Metrics

TTM

$366M

Revenue

+7.8% YoY

$9M

Net Income

+213.1% YoY

$26M

Free Cash Flow

-13.6% YoY

83.9%

Gross Margin

-0.1%

Op. Margin

1.8%

Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE3.6%

ROA2.0%

ROIC3.2%

Valuation

P/E66.6

P/B2.7

EV/EBITDA21.8

Leverage

Debt/Equity0.42

Current Ratio3.01

Interest Cov.2.1x

Quality Scores

Piotroski F7/9

Altman Z3.61

Beneish M-2.55